Search results for “Haemolytic-uraemic syndrome” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 62 patents, we discovered top 22 key players by total patent application. Alexion Pharmaceuticals, Inc., Glaxo Group Ltd., Novartis AG are dominant in this area. They take 35.48% of the total patent filing.
Alexion Pharmaceuticals, Inc.
Connecticut, United States
Patent: 12
Glaxo Group Ltd.
Hounslow, United Kingdom
Patent: 5
Novartis AG
Basel-Stadt, Switzerland
Patent: 4
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 4
Hawker Resources, Inc.
Alberta, Canada
Patent: 4
Baxter AG
ZURICH, Switzerland
Patent: 3
Daiichi Sankyo Co., Ltd.
New Jersey, United States
Patent: 2
Fuso Pharmaceutical Industries Ltd.
Osaka-fu, Japan
Patent: 2
Omeros Corp.
Washington, United States
Patent: 2
Laboratoire Francais du Fractionnement et des Biotechnologies S.A.
France
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 34 patents applied in the last 5 years. We discover 9 most active companies in this area. The fast-growing Alexion Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., The National Centre For Cell Sciences take 50.00% of patent filing during this period.
Alexion Pharmaceuticals, Inc.
Connecticut, United States
Patent: 10
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 4
The National Centre For Cell Sciences
Maharashtra, India
Patent: 3
Alma Mater Studiorum - Università di Bologna
Emilia-Romagna, Italy
Patent: 3
Silence Therapeutics GmbH
Berlin, Germany
Patent: 2
Xi'an Tianhong Biotechnology Co., Ltd.
Shaanxi Sheng, China
Patent: 1
Novartis AG
Basel-Stadt, Switzerland
Patent: 1
The General Hospital Corp.
Massachusetts, United States
Patent: 1
Shanghai Puming Biotechnology Co., Ltd.
Shanghai Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 34 patents in last 5 years, we discover 7 new entrants. Alnylam Pharmaceuticals, Inc., The National Centre For Cell Sciences, Alma Mater Studiorum - Università di Bologna are the most active new entrants in this area.
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 4
The National Centre For Cell Sciences
Maharashtra, India
Patent: 3
Alma Mater Studiorum - Università di Bologna
Emilia-Romagna, Italy
Patent: 3
Silence Therapeutics GmbH
Berlin, Germany
Patent: 2
Xi'an Tianhong Biotechnology Co., Ltd.
Shaanxi Sheng, China
Patent: 1
The General Hospital Corp.
Massachusetts, United States
Patent: 1
Shanghai Puming Biotechnology Co., Ltd.
Shanghai Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 22 patents, we discovered top 5 universities and scientific research institutions by total patent application. The Johns Hopkins University, Alma Mater Studiorum - Università di Bologna, Keio University are dominant in this area. They take 40.91% of the total patent filing.
The Johns Hopkins University
United States
Patent: 3
Alma Mater Studiorum - Università di Bologna
Emilia-Romagna, Italy
Patent: 3
Keio University
Tokyo-to, Japan
Patent: 2
University of Leicester
LEICESTER, United Kingdom
Patent: 2
Consejo Superior de Investigaciones Científicas
Madrid, Spain
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: